查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1942531

2026年全球心血管植入市場報告

Cardiovascular Implants Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心血管植入市場成長顯著，預計將從2025年的286.8億美元成長到2026年的305.2億美元，複合年成長率為6.4%。過去幾年的成長可歸因於多種因素，例如心血管疾病盛行率的上升、介入性心臟病手術的增加、醫院心臟護理部門的擴張、植入式心臟心律調節器的日益普及以及先進生物材料的廣泛應用。

預計未來幾年心血管植入市場將穩定成長，到2030年市場規模將達390.9億美元，複合年成長率（CAGR）為6.4%。預測期內的成長要素包括人口老化、對微創心臟手術需求的成長、結構性心臟疾病治療方法的不斷豐富、對個人化心血管護理的日益重視，以及植入材料和設計方面的技術創新。預測期內的主要趨勢包括微創心血管植入的日益普及、藥物釋放型支架和生物可吸收支架的廣泛應用、經導管心臟瓣膜置換術的日益受到青睞、先進心臟節律管理裝置的日益普及，以及對植入物長期耐久性的日益關注。

預計未來幾年，心臟病盛行率的不斷上升將推動心血管植入市場的成長。心臟病是指影響心臟和血管的各種疾病，例如冠狀動脈疾病、心臟衰竭、心律不整和瓣膜疾病。冠狀動脈疾病和心臟衰竭等心臟病的增加，推動了包括支架和心律調節器在內的心血管植入的需求成長。這些植入能夠支持心臟功能和血液循環，調節心率，並監測心臟衰竭患者的心臟活動。例如，英國心臟基金會（BHF）是一家致力於資助心臟和循環系統疾病研究並提高公眾意識的英國慈善機構，該機構於2024年9月報告稱，英國約有760萬人患有心臟和循環系統疾病。預計到2030年，這數字將增加100萬，到2040年將再增加200萬。因此，心臟病患病率的上升趨勢正在推動心血管植入市場的擴張。

心血管植入市場的主要企業正致力於整合包括人工智慧 (AI) 在內的先進技術，以最大限度地提高市場利潤並改善患者照護和治療。心臟監測技術的進步包括持續追蹤和記錄患者的心率活動，用於診斷和管理心臟疾病。 2023 年 6 月，百多力 (BIOTRONIK SE & Co. KG) 推出了 BIOMONITOR IV，這是全球首款將智慧心電圖 (SmartECG) 技術與人工智慧相結合的植入式心臟監測器 (ICM)。這項創新技術可將假陽性檢測率降低 86%，同時維持 98% 的實際癲癇發作檢測準確率。 BIOMONITOR IV 還具有其他優勢，例如更長的電池續航時間和無線連接功能，可實現無縫資料傳輸和遠端監測，從而減少患者頻繁就醫的需求。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球心血管植入市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 微創心血管植入的應用日益普及
    • 藥物釋放型和生物可吸收支架的使用日益增多
    • 增加經導管心臟瓣膜置換術的選擇
    • 擴展先進心臟節律管理設備
    • 越來越重視植入的長期耐久性

第5章 終端用戶產業市場分析

  • 醫院
  • 心臟中心
  • 門診手術中心
  • 專科心臟診所
  • 介入性心臟病中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球心血管植入市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球心血管植入市場規模、對比及成長率分析
  • 全球心血管植入市場表現：規模與成長，2020-2025年
  • 全球心血管植入市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 冠狀動脈支架、植入式心臟整流去顫器（ICD）、心臟瓣膜、植入式心臟節律器、心臟再同步治療（CRT）裝置、周邊支架
  • 材料
  • 金屬及合金、聚合物、生物材料
  • 透過使用
  • 心律不整、急性心肌梗塞、心肌缺血等適應症
  • 最終用戶
  • 醫院、門診手術中心及心臟中心
  • 按類型細分：冠狀動脈支架
  • 藥物釋放型支架、裸金屬支架、生物可吸收支架
  • 依類型細分：植入式心臟整流去顫器（ICD）
  • 單腔ICD、雙腔ICD、雙心室ICD
  • 按類型細分：心臟瓣膜
  • 人工心臟瓣膜、生物人工心臟瓣膜、經​​導管心臟瓣膜
  • 按類型細分：植入式心臟節律器
  • 單腔心律調節器、雙腔心律調節器、雙心室節律器
  • 依類型細分：心臟再同步治療（CRT）設備
  • CRT-P裝置（心臟節律器）、CRT-D裝置（去心房顫動）
  • 按類型細分：周邊支架
  • 頸動脈支架、腎動脈支架、股動脈支架

第10章 區域與國家分析

  • 全球心血管植入市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球心血管植入市場：依國家分類、績效及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 心血管植入市場：競爭格局與市場佔有率（2024 年）
  • 心血管植入市場：公司估值矩陣
  • 心血管植入市場：公司概況
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • Edwards Lifesciences Corporation

第37章：其他領先和創新企業

  • WL Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年心血管植入市場：提供新機會的國家
  • 2030年心血管植入市場：充滿新機會的細分市場
  • 2030年心血管植入市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MCIMP04_G26Q1

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

Tariffs are influencing the cardiovascular implants market by increasing costs of imported metals, polymers, electronic components, and precision manufacturing equipment used in stents, pacemakers, valves, and defibrillators. Hospitals and cardiac centers in North America and Europe are most affected due to dependence on imported implant components, while Asia-Pacific faces cost pressure on export manufacturing. These tariffs are elevating device prices and affecting procurement budgets. At the same time, they are supporting localized manufacturing, regional supply chain development, and innovation in cost-optimized cardiovascular implant technologies.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $28.68 billion in 2025 to $30.52 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising interventional cardiology procedures, expansion of hospital cardiac care units, growing adoption of implantable pacemakers, availability of advanced biomaterials.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $39.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive cardiac treatments, expansion of structural heart disease therapies, growing focus on personalized cardiovascular care, increasing innovation in implant materials and designs. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular implants, rising use of drug-eluting and bioabsorbable stents, growing preference for transcatheter heart valve procedures, expansion of advanced cardiac rhythm management devices, enhanced focus on long-term implant durability.

The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd

North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents
  • 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
  • 3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
  • 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
  • 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
  • 6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; Cook Medical Incorporated; Kyoto Medical Planning Co. Ltd.; Abiomed Inc.; Livanova PLC; BIOTRONIK SE & Co. KG; CryoLife Inc.; Endologix Inc.; Sorin Group; Berlin Heart GmbH; REVA Medical LLC.; Syncardia Systems LLC; Elixir Medical Corporation; Proxy Biomedical Ltd.; Calon Cardio-Technology Ltd.; InspireMD Inc.; Neovasc Inc.; Shree Pacetronix Ltd.; Vascutek Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiovascular Implants Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiovascular Implants Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiovascular Implants Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiovascular Implants Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Cardiovascular Implants
    • 4.2.2 Rising Use Of Drug-Eluting And Bioabsorbable Stents
    • 4.2.3 Growing Preference For Transcatheter Heart Valve Procedures
    • 4.2.4 Expansion Of Advanced Cardiac Rhythm Management Devices
    • 4.2.5 Enhanced Focus On Long-Term Implant Durability

5. Cardiovascular Implants Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiac Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Heart Clinics
  • 5.5 Interventional Cardiology Centers

6. Cardiovascular Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiovascular Implants Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiovascular Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiovascular Implants Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiovascular Implants Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiovascular Implants Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiovascular Implants Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiovascular Implants Market Segmentation

  • 9.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
  • 9.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metals and Alloys, Polymers, Biological Materials
  • 9.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
  • 9.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Cardiac Centers
  • 9.5. Global Cardiovascular Implants Market, Sub-Segmentation Of Coronary Stent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
  • 9.6. Global Cardiovascular Implants Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
  • 9.7. Global Cardiovascular Implants Market, Sub-Segmentation Of Heart Valve, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
  • 9.8. Global Cardiovascular Implants Market, Sub-Segmentation Of Implanted Cardiac Pacemaker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
  • 9.9. Global Cardiovascular Implants Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT) Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
  • 9.10. Global Cardiovascular Implants Market, Sub-Segmentation Of Peripheral Stent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

10. Cardiovascular Implants Market Regional And Country Analysis

  • 10.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiovascular Implants Market

  • 11.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiovascular Implants Market

  • 12.1. China Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiovascular Implants Market

  • 13.1. India Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiovascular Implants Market

  • 14.1. Japan Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiovascular Implants Market

  • 15.1. Australia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiovascular Implants Market

  • 16.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiovascular Implants Market

  • 17.1. South Korea Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiovascular Implants Market

  • 18.1. Taiwan Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiovascular Implants Market

  • 19.1. South East Asia Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiovascular Implants Market

  • 20.1. Western Europe Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiovascular Implants Market

  • 21.1. UK Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiovascular Implants Market

  • 22.1. Germany Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiovascular Implants Market

  • 23.1. France Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiovascular Implants Market

  • 24.1. Italy Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiovascular Implants Market

  • 25.1. Spain Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiovascular Implants Market

  • 26.1. Eastern Europe Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiovascular Implants Market

  • 27.1. Russia Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiovascular Implants Market

  • 28.1. North America Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiovascular Implants Market

  • 29.1. USA Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiovascular Implants Market

  • 30.1. Canada Cardiovascular Implants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiovascular Implants Market

  • 31.1. South America Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiovascular Implants Market

  • 32.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiovascular Implants Market

  • 33.1. Middle East Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiovascular Implants Market

  • 34.1. Africa Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiovascular Implants Market, Segmentation By Product, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiovascular Implants Market Regulatory and Investment Landscape

36. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 36.1. Cardiovascular Implants Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiovascular Implants Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiovascular Implants Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Cardiovascular Implants Market Other Major And Innovative Companies

  • W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd.

38. Global Cardiovascular Implants Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiovascular Implants Market

40. Cardiovascular Implants Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiovascular Implants Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiovascular Implants Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiovascular Implants Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer